Ottimo Pharma Funding: $140M Raised, Series A (2024)
Ottimo Pharma is a Biotech company based in London, United Kingdom. It has raised $140M in total funding. Latest round: Series A. Backed by Medicxi.
Ottimo Pharma funding overview
Ottimo Pharma is a Biotech company based in London, United Kingdom. Ottimo Pharma has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Ottimo Pharma runs through 2024; nothing later has been disclosed. Investors on record include Medicxi.
Ottimo Pharma at a glance
Total raised
$140M
Latest round
Series A
Latest round date
December 2024
Industry
Biotech
Headquarters
London, United Kingdom
Notable investors
Medicxi
Frequently asked about Ottimo Pharma funding
How much has Ottimo Pharma raised?
Ottimo Pharma has raised $140M in total disclosed funding across the rounds on record.
Who has invested in Ottimo Pharma?
Medicxi are named among the investors backing Ottimo Pharma.
What was the latest Ottimo Pharma funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is Ottimo Pharma based?
Ottimo Pharma is based in London, United Kingdom.
What sector does Ottimo Pharma operate in?
Ottimo Pharma is tracked under Biotech from London, United Kingdom, with $140M in disclosed funding.
When did Ottimo Pharma last raise?
The last disclosed Ottimo Pharma round closed in December 2024 at Series A.
We update the Ottimo Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in London and their backers are listed below.
